8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Dec 22, 2023 · 2y ago · Accession 0001193125-23-301777
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Kalaris Therapeutics, Inc.
- Ticker
- KLRS
- CIK
- 1754068
- Form type
- 8-K
- Filing date
- Dec 22, 2023
- Report date
- Dec 22, 2023
- Document
- d671953d8k.htm
- Size
- 166 KB